<DOC>
	<DOCNO>NCT01596738</DOCNO>
	<brief_summary>The use platelet aggregation inhibitor , include aspirin clopidogrel , become standard management strategy patient acute coronary syndrome . On background , increase percentage patient present surgical coronary revascularization subject irreversible platelet inhibition . Tranexamic acid widely use antifibrinolytic agent , promise substitute aprotinin latter suspend 2007.The release plasmin CPB activate fibrinolysis may contribute platelet dysfunction . Pharmacological inhibition fibrinolytic system may therefore ameliorate platelet dysfunction fibrinolysis CPB decrease postoperative bleeding . Tranexamic acid prevents plasmin formation inhibits fibrinolysis . Many study meta-analyses show reduction postoperative bleeding transfusion requirement antifibrinolytic drug cardium revascularization surgery . Unfortunately preoperative antiplatelet therapy either neglected obscure . Few study specify time last clopidogrel ingestion surgery.Several study keen blood loss allogeneic transfusion patient receive last clopidogrel asprin within 7 day prior coronary artery bypass grafting . Concerning secession aprotinin increase proportion patient persistence clopidogrel surgery , evolutional work expect , especially eastern population . The purpose study assess effect tranexamic acid patient clopidogrel asprin ingestion le 7 day prior surgery . The work hypothesis tranexamic acid would reduce bleed transfusion requirement specific population patient .</brief_summary>
	<brief_title>Tranexamic Acid On-pump CABG With Premature Clopidogrel Cessation</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Men woman age 1885 year undergo primary isolated onpump CABG Last ingestion clopidogrel aspirin within 7 day preoperatively Previous cardiac surgery Hematocrit &lt; 33 % Platelet count &lt; 100,000/ml Allergy tranexamic acid Recruited study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Artery Bypass Graft</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Tranexamic Acid</keyword>
</DOC>